ARTBIO Strengthens Leadership with Four New Board Members and Advisory Role for Co-Founder ARTBIO, a clinical-stage radiopharmaceutical company, has appointed four new board members and shifted its co-founder to an advisory role, aiming to enhance its alpha radioligand therapy programs.

ARTBIO Strengthens Leadership with Four New Board Members and Advisory Role for Co-Founder #United_States #Cambridge #ARTBIO #Alpha_Radioligand #Roy_Larsen